Skip to content

UPL Ltd.

NSE: UPLBasic MaterialsAgricultural Inputs

Last close
₹508.65
Day change
−₹5.45 (−1.06%)vs
Market cap
₹44,352 crIndian rupees
Research updated
1 report
Follow UPL

Create an account, then follow this company for weekday briefs. You will return to UPL after signing in.

About UPL

UPL Ltd. is a multinational agrochemical company that provides innovative crop protection and agriculture solutions globally. The primary function of UPL Ltd. is to foster sustainable agriculture through the provision of agrochemicals, specialty chemicals, and industrial chemicals. UPL's offerings include herbicides, insecticides, fungicides, plant growth regulators, and rodenticides, crucial for improving crop yield and quality. Operating across more than 130 countries, UPL Ltd. has extensive reach and plays a significant role in the agricultural industry by enhancing productivity and supporting food security. The company’s Research & Development initiatives focus on sustainability, helping to address challenges such as pest resistance and environmental impact. UPL Ltd.'s strategic acquisitions and partnerships enable it to expand its market presence and drive innovation within the sector. The company is a vital player in shaping agricultural practices and significantly contributes to the global food supply chain, holding a strong market position among leading agrochemical firms.

Sector
Basic Materials
Industry
Agricultural Inputs
Listing
NSE: UPL
Chief executive
Mr. Jaidev Rajnikant Shroff B.Sc.
Employees
12,399
Headquarters
Mumbai, India
ISIN
INE628A01036

Public research · Report of

Business model & financial foundation

UPL (NSE: UPL), Crop protection, seeds and specialty chemicals: revenue of ₹51,839 crore in FY26 (+11.2% on FY25), an EBITDA margin of 18.5%, net profit of ₹1,922 crore and net debt of ₹15,325 crore.

Key figures
Revenue, FY26 (₹ crore)
51,839
consolidated
Revenue growth, FY26
+11.2%
on FY25
EBITDA margin, FY26
18.5%
EBITDA (Issuer EBITDA before trade FX, other income and D&A) / revenue
Net profit, FY26 (₹ crore)
1,922
to owners
Return on equity, FY26
4.9%
on average equity
Net debt, FY26 (₹ crore)
15,325
Company net debt incl liquid investments, FY25 perpetual
Market capitalisation (₹ crore)
46,757
at the close of 14 Oct 2026

Company profile

UPL supplies crop-protection formulations, biological solutions, seeds and specialty chemicals across global agriculture. International crop protection, India formulations, Advanta seeds/post-harvest and SUPERFORM manufacturing have distinct economics. Registrations, germplasm, integrated manufacturing and distribution support market access, but farm credit, weather, generic pricing and seasonal working capital determine cash generation.

Item, Value
ItemValue
Legal nameUPL Limited
Exchange and tickerNSE: UPL; BSE: 512070
ISININE628A01036
CINL24219GJ1985PLC025132
SectorChemicals
IndustryCrop protection, seeds and specialty chemicals
HeadquartersMumbai, India
Fiscal year endMarch
Reporting basis and unitconsolidated, in ₹ crore
AuditorB S R & Co. LLP
Market capitalisation₹46,757 crore (14 Oct 2026)
Shares outstanding84.42 crore shares (FY26)
Price₹524.7 (close, 14 Oct 2026)
52-week range₹476.5 - ₹812.2 (to 14 Oct 2026)
Websitehttps://www.upl-ltd.com

Corporate structure and shareholding

Entity, Holding, Business
EntityHoldingBusiness
UPL Corporation Cayman78%International crop protection platform
Advanta Enterprises78%Seeds and post-harvest platform including Decco
UPL Sustainable Agri Solutions91%India crop protection
SUPERFORM Chemistries100%Captive active ingredients and specialty chemicals
UPL Global Sustainable Agri Solutions100%Proposed combined crop protection platform

Composite crop-protection scheme pending approvals. Management platform numbers require intercompany eliminations and differ from statutory segments.

Shareholding (% of shares)
Shareholding (% of shares)Q2FY26Q3FY26Q4FY26Q1FY27
Promoter33.50%33.50%33.51%33.51%
Promoter holding pledged0.00%0.00%0.00%0.00%
Foreign institutions37.01%38.84%41.78%42.39%
Domestic institutions17.16%16.72%14.63%14.32%
of which mutual funds7.45%7.68%7.23%8.57%
Retail6.84%6.57%6.58%6.41%
Other5.48%4.37%3.49%3.37%

The promoter holding pledged is a share of the promoter's own holding.

Business model

UPL earns from global crop protection, India farm solutions, Advanta seeds/post-harvest and SUPERFORM specialty/industrial chemistry. Consolidated accounts are the security's economic scope; internal platform revenue must be eliminated. FY26 Corp revenue 38,277cr dominates, Advanta 6,837cr supplies higher-margin growth. Consolidated FY26 sales 51,839cr reconcile after 6,785cr eliminations.

Segment, revenue, FY26 (₹ crore), Share, ebitda, FY26 (₹ crore)
Segmentrevenue, FY26 (₹ crore)Shareebitda, FY26 (₹ crore)Sharecontribution margin, FY26 (%)
UPL Corp international CP (management proforma)38,27717.9%6,00863.0%35.1%
UPL SAS India CP proforma EXCLUDING Nurture3,2121.5%548.05.7%32.2%
Advanta INCLUDING Decco common-control recast6,8373.2%1,72518.1%56.3%
SUPERFORM chemistries proforma incl captive AI sales10,2984.8%1,25813.2%24.7%
Ind AS crop protection EXCLUDING Decco (AR26 recast)42,20619.7%
Ind AS Seeds AND Post-Harvest (AR26 recast)6,8303.2%
Ind AS Non-Agro (NOT total SUPERFORM)2,8031.3%
Country revenue Brazil (customer location)11,1535.2%
Country revenue India (customer location)6,3433.0%
Country revenue USA (customer location)6,2932.9%
Country revenue United Kingdom (customer location)328.00.2%
Other countries revenue (NOT regional ROW)27,72212.9%
Consolidated region Latin America19,3589.0%
Consolidated region North America7,1823.4%
Consolidated region Europe8,1673.8%
Consolidated region India NOT UPL SAS only6,3433.0%
Consolidated region Rest of World10,7895.0%

Segments as the company reports them (consolidated); each share is of the segments' sum.

Peer, Why the dossier compares them
PeerWhy the dossier compares them
PI Industries (PIIND)Crop-protection contract manufacturing and domestic formulations; premium mix.
Bayer CropScience (BAYERCROP)India crop protection and seeds; innovator-backed portfolio.
Sumitomo Chemical India (SUMICHEM)India agrochemical formulations and parent-backed technology.
Rallis India (RALLIS)Domestic crop protection, manufacturing and seeds.
Dhanuka Agritech (DHANUKA)India branded crop-protection distribution; asset-light comparison.

Financial databook

Profit and loss (₹ crore)
Profit and loss (₹ crore)FY22FY23FY24FY25FY26
Revenue from operations including other operating revenue45,97153,13443,09846,63751,839
Cost of revenue (vendor classification) *22,38627,62124,76724,52626,215
Other operating costs (vendor classification) *8,5529,0187,3177,8348,839
EBITDA (vendor classification) *9,37810,9674,3877,3839,916
Statutory pre-finance profit incl other income6,7418,1342,2595,3366,691
Statutory gross finance cost incl FX, leases, unwinding1,7752,9843,8523,6273,401
Profit/(loss) before tax4,9665,150-2,087829.03,157
Tax expense/(credit)529.0736.0-209.09.00937.0
Group profit/(loss) after tax before minorities4,4374,414-1,878820.02,220
Diluted EPS adjusted for rights bonus element (₹)44.0043.92-17.459.6222.32
PAT attributable to non-controlling interests-678.0-77.0298.0
Profit/(loss) attributable to parent owners-1,200897.01,922
Issuer EBITDA before trade FX, other income and D&A5,5158,1249,588
Perpetual coupon deducted in EPS numerator136.0138.070.0
Raw and packing materials consumed19,13318,28923,928
Purchases of stock in trade4,4454,2083,808
Inventory changes: positive expense, negative income916.01,726-1,845
Materials, traded goods and inventory change24,49424,22325,891
Employee benefits expense4,6825,3095,807
Other expenses per statutory P&L8,3168,7459,803
Impairment loss on financial assets91.0240.0750.0
Trade receivable/payable exchange loss976.0520.0316.0
Other income per statutory P&L483.0486.0663.0
Depreciation and amortisation including impairments2,7632,7503,244
Share of associates and JV profit/(loss), signed-242.0-472.0-194.0
Exceptional gain/(loss), signed-252.0-408.061.0
Current tax expense/(credit)790.0295.01,243
Deferred tax expense/(credit)-999.0-286.0-306.0
Financial FX expense/(gain) included in gross finance cost314.0191.0328.0
Parent-owners PAT less perpetual coupon for EPS-1,336759.01,852
Issuer EBITDA minus rounded statutory operating cost stack0.004.000.00
Residual after statutory EBITDA-to-PBT bridge0.000.000.00
Balance sheet (₹ crore)
Balance sheet (₹ crore)FY22FY23FY24FY25FY26
Total equity including minorities and perpetual29,30835,42932,70637,82641,269
Borrowings excluding leases and perpetual equity26,70923,93928,43823,71422,046
Cash and cash equivalents5,7975,9675,9439,4785,975
Net trade receivables current plus noncurrent15,84318,28216,36415,51218,343
Inventories13,07813,98512,77610,31612,676
Trade payables excluding rebate/refund liabilities16,55217,61412,63110,86712,018
Net PPE excluding right-of-use assets195.09,0708,4438,1078,474
Capital work in progress excluding intangible development1,2651,2511,106615.0999.0
Total assets82,67988,57787,54688,00295,205
Equity attributable to parent owners24,80729,21334,696
Current investments (not all FY25 counted as liquidity)261.0320.0634.0
Non-current financial investments excluding associates/JVs655.0614.0770.0
Company cash/bank/liquid investmentsn.r.9,8566,720
Company net debt incl liquid investments, FY25 perpetualn.r.17,26715,325
Cash flow (₹ crore)
Cash flow (₹ crore)FY22FY23FY24FY25FY26
Net operating cash flow incl operating exchange differences989.06,4162,32110,1517,855
Free cash flow (vendor definition) *3,8085,391-173.08,4565,449
Cash dividends paid, positive outflow, excluding NCI-764.0-750.0749.077.0478.0
Gross cash capex PPE plus intangibles, positive outflow-1,899-1,6011,9951,6952,406
Cash purchase PPE, CWIP and capital advances1,159813.01,666
Cash purchase intangible assets and development836.0882.0740.0
Gross repayment of non-current debt, positive outflow1,6612,1374,742
Perpetual securities redemption cash outflow3,409
Other reported lines (₹ crore)
Other reported lines (₹ crore)FY22FY23FY24FY25FY26
Issued outstanding shares at year end (incl partly paid FY25)79.6578.2575.0684.4484.42
Disclosed weighted average diluted EPS denominator (crore shares)76.5578.9382.99
Quarterly profit and loss (₹ crore)
Quarterly profit and loss (₹ crore)Q2FY25Q3FY25Q4FY25Q1FY26Q2FY26Q3FY26Q4FY26Q1FY27
Revenue from operations11,09010,90715,5739,21612,01912,26918,33510,181
Cost of revenue (vendor classification) *5,8235,3298,5514,1695,84610,1234,315
Other operating costs (vendor classification) *2,2032,2512,3142,2302,5462,5462,733
EBITDA (vendor classification) *1,6311,9273,2911,4782,3194,0381,597
Statutory pre-finance profit including other income766.01,4382,593808.01,4801,5822,821835.0
Finance costs, statutory gross including financial forex1,070730.0914.01,007784.0774.0836.0852.0
Profit before tax after associates and exceptional items-447.0354.01,377-190.0784.0671.01,892-109.0
Total income tax expense or credit138.0-499.0298.0-14.0172.0181.0598.0-36.0
Profit after tax including non-controlling interests-585.0853.01,079-176.0612.0490.01,294-73.0
Diluted EPS, latest available comparative basis (₹)-5.689.7011.15-1.946.744.6912.570.12
Material cost including purchases and inventory changes5,8235,3298,5514,1695,7535,84610,1234,315
Employee benefits expense1,3371,1841,4511,3221,4661,3791,6401,527
Other expenses, statutory line2,2032,2512,3142,2302,4812,5462,5462,733
EBITDA, issuer presentation definition1,5762,1633,2401,3032,2052,4343,6461,500
Other income, statutory gross111.0170.0107.0143.0250.092.0178.0217.0
Depreciation and amortisation expense697.0688.0705.0731.0771.0827.0915.0832.0
Exceptional items, signed gain or loss contribution-8.00-76.0-275.0-9.00142.0-56.0-16.0-9.00
Share of associates and joint ventures profit or loss, signed-135.0-278.0-27.018.0-54.0-81.0-77.0-83.0
PAT attributable to non-controlling interests, signed-142.025.0183.0-88.059.094.0233.0-83.0
PAT attributable to owners of UPL Ltd-443.0828.0896.0-88.0553.0396.01,06110.0
Impairment loss on financial assets, net expense152.0-19.020.0192.0114.065.0379.0106.0
Exchange differences on trade balances, expense positive223.0206.046.0-93.0204.0116.089.050.0
Financial forex and hedging expense included in finance costs151.0-98.039.0271.031.074.0-48.093.0
Current income tax expense or credit258.0-424.0272.0205.0363.0187.0488.0309.0
Deferred income tax expense or credit-120.0-75.026.0-219.0-191.0-6.00110.0-345.0
Impairment loss on financial assets, net152.0-19.020.0192.0114.065.0379.0106.0
Trade receivable/payable exchange loss/(gain), net223.0206.046.0-93.0204.0116.089.050.0
Issuer EBITDA minus rounded statutory operating cost stack1.001.003.000.000.001.00-1.000.00
Residual after statutory EBITDA-to-PBT bridge0.000.000.000.000.000.000.000.00
Perpetual coupon deduction from EPS numeratorn.r.n.r.n.r.70.00.000.000.000.00
Parent-owners PAT less perpetual coupon for EPSn.r.n.r.n.r.-158.0553.0396.01,06110.0
Raw and packing materials consumed per statutory detail4,8854,9705,7964,9616,1366,3626,4695,621
Purchases of stock in trade per statutory detail843.0144.01,0361,414709.01,117568.01,472
Inventory changes: positive expense, negative release95.0215.01,719-2,206-1,092-1,6333,086-2,778

Consolidated, as reported. Lines marked * are the market-data provider's figures; the rest are extracted from the company's filings or derived from them. n.d. not disclosed, n.r. not retrieved, n.a. not applicable.

Metrics dashboard

Metric, FY22, FY23, FY24
MetricFY22FY23FY24FY25FY26
Revenue growth19.7%15.6%-18.9%8.2%11.2%
EBITDA margin12.8%17.4%18.5%
Net margin-2.8%1.9%3.7%
Return on equity-3.5%2.5%4.9%
Return on capital employed12.8%14.1%3.7%8.7%10.7%
Return on assets-1.4%1.0%2.1%
Net debt (₹ crore)17,26715,325
Net debt / EBITDA2.13x1.60x
Interest cover3.80x2.73x0.59x1.47x1.97x
Asset turnover0.60x0.62x0.49x0.53x0.57x
Receivable days126126139121129
Inventory days (on revenue)104961088189
Payable days (on revenue)1311211078585
Cash conversion-1.93x11.3x4.09x
Capex intensity4.1%3.0%4.6%3.6%4.6%
Free cash flow (₹ crore)-910.04,815326.08,4565,449
Dividend payout-62.4%8.6%24.9%
EPS, diluted (₹)44.0043.92-17.459.6222.32
Book value per share (₹)368.0452.8435.7447.9488.9

Computed from the statements above:

  • Revenue growth: revenue over the previous year's, less one.
  • EBITDA margin: EBITDA (Issuer EBITDA before trade FX, other income and D&A) / revenue.
  • Net margin: net profit to owners / revenue.
  • Return on equity: net profit to owners / average equity.
  • Return on capital employed: EBIT / average equity plus borrowings.
  • Return on assets: net profit to owners / average total assets.
  • Net debt (₹ crore): Company net debt incl liquid investments, FY25 perpetual; negative is net cash.
  • Net debt / EBITDA: net debt / EBITDA (Issuer EBITDA before trade FX, other income and D&A).
  • Interest cover: EBIT / finance cost.
  • Asset turnover: revenue / average total assets.
  • Receivable days: receivables / revenue x 365.
  • Inventory days (on revenue): inventory / revenue x 365.
  • Payable days (on revenue): payables / revenue x 365.
  • Cash conversion: cash from operations / net profit to owners.
  • Capex intensity: capital expenditure / revenue.
  • Free cash flow (₹ crore): cash from operations less capital expenditure.
  • Dividend payout: dividends paid / net profit to owners.
  • EPS, diluted (₹): as reported (Diluted EPS adjusted for rights bonus element).
  • Book value per share (₹): equity / shares outstanding.

Source: the company's filings and disclosures as extracted into Mool's company dossier (version 1, information to 14 Oct 2026); market data at the close of 14 Oct 2026. Every figure is read from the dossier's files or computed from them; the account of the business model is the analyst's, from the dossier's workings.

With Individual or above

What the full research on UPL includes

Every piece of Mool’s research is built the same way: a researched evidence base, analyses that build on each other, a research model and a report with the call. This page shows the first analysis.

The report and Mool’s call

  • The 12-month rating and target
  • The 3-month view
  • Mool's estimates beside the street's
  • The claims the view rests on, and what would change it

The analyses, among them

  • Business model & financial foundationOn this pageWhat the company does and how it makes money, its structure, five years of financials and the metrics that matter for it.
  • Future earnings & financial modelForecasts built from the drivers that move the business, by scenario, beside the street's.
  • Fundamental valuation & 12-month thesisWhat the business is worth on several methods, what the market already prices in and the 12-month thesis that follows.

The research model

The model behind the report: the company’s history, the drivers that move it, its forecasts by scenario and the valuation the 12-month target comes from.

See Mool’s call and the full research

Individual or above opens every piece of research Mool has published. A new account can start with 10 days of Pro, or of Firm on a work email address. No card needed.

Report history

Reports on UPL

  1. Research reportLatest

Same sector

All Basic Materials companies
  • Ultratech Cement Ltd.

    NSE: ULTRACEMCO

    Basic Materials · Building Materials

    ₹11,050.00 last close on 23 Oct 2026 +0.84%

    Research updated

  • JSW Steel Ltd.

    NSE: JSWSTEEL

    Basic Materials · Steel

    ₹1,185.50 last close on 23 Oct 2026 −2.83%

    Research updated

  • Asian Paints Ltd.

    NSE: ASIANPAINT

    Basic Materials · Specialty Chemicals

    ₹2,307.00 last close on 23 Oct 2026 +0.97%

    Research updated

  • Hindustan Zinc Ltd.

    NSE: HINDZINC

    Basic Materials · Other Industrial Metals & Mining

    ₹496.00 last close on 23 Oct 2026 −4.25%

    Research updated

  • Tata Steel Ltd.

    NSE: TATASTEEL

    Basic Materials · Steel

    ₹167.67 last close on 23 Oct 2026 −2.70%

    Research updated

  • Basic Materials · Aluminum

    ₹869.85 last close on 23 Oct 2026 −1.78%

    Research updated

Prices are the last close on the NSE, 23 Oct 2026. Research from Mool’s report of 14 Oct 2026; page updated 25 Oct 2026.

Mool’s research is written by AI agents and published by Mool Capital Private Limited, a SEBI-registered Research Analyst, registration INH000012449, which is responsible for it. This page shows factual company information and an excerpt of that research; it carries no rating and is not investment advice for any individual. Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. Read the disclosures.